Extendicare (EXETF) Stock Price, News & Analysis

Company Overview

Extendicare Inc. (OTCMKTS:EXETF) is a Canada-based senior care provider headquartered in Markham, Ontario. The company specializes in the ownership and operation of long-term care homes, retirement residences and home health care services. It is publicly listed on the Toronto Stock Exchange under the symbol EXE and trades in the over-the-counter market as EXETF.

Extendicare’s operations are organized into two primary segments. The Long-Term Care & Retirement Living division operates approximately 120 facilities under the Extendicare and EspritVitalité banners, serving residents in Ontario, Alberta, Saskatchewan and parts of Atlantic Canada. The Home Health Care segment provides in-home personal support, nursing and allied health services through its ParaMed brand, primarily in Ontario.

Founded in 1962, the company has grown through a combination of strategic acquisitions and organic development of new care properties. Extendicare’s governance and senior leadership team bring extensive experience in healthcare management, with a focus on regulatory compliance, quality assurance and continuous improvement of resident and patient outcomes.

Key Stats

• Today's Range: $10.61 to $36.80
• 50-Day Range: $9.34 to $36.80
• 52-Week Range: $6.50 to $36.80
• Volume: 950,609 shs
• Average Volume: 9,325 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 1.30%
• Price Target: N/A
• Consensus Rating: Hold

Extendicare Stock Analysis - MarketRank™

Extendicare scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Extendicare.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Extendicare is -141.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Extendicare is -141.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Extendicare has a short interest ratio ("days to cover") of 129.7, which indicates bearish sentiment.

Change versus previous month

Short interest in Extendicare has recently decreased by 5.20%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

Extendicare is a leading dividend payer. It pays a dividend yield of 8.00%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Extendicare does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Extendicare has a short interest ratio ("days to cover") of 129.7, which indicates bearish sentiment.

Change versus previous month

Short interest in Extendicare has recently decreased by 5.20%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: 0.34

News Sentiment

Extendicare has a news sentiment score of 0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.49 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Extendicare this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Extendicare insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 9.44% of the stock of Extendicare is held by institutions.

EXETF Stock Analysis - Frequently Asked Questions

How have EXETF shares performed this year?

Extendicare's stock was trading at $7.27 at the start of the year. Since then, EXETF shares have increased by 406.2% and is now trading at $36.80.

How do I buy shares of Extendicare?

Shares of EXETF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Ex-Dividend for 9/15 Dividend: 8/29/2025
• Record date for 9/15 Dividend: 9/01/2025
• Dividend Payable: 9/15/2025
• Ex-Dividend for 10/15 Dividend: 9/30/2025
• Record date for 10/15 Dividend: 10/01/2025
• Dividend Payable: 10/15/2025
• Today: 10/20/2025
• Next Earnings (Estimated): 11/11/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Care Facilities
• Sub-Industry: Trading
• Current Symbol: OTCMKTS:EXETF
• CIK: N/A
• Web: www.extendicare.com
• Phone: (905) 470-4000
• Fax: N/A
• Employees: 23,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A